← FDA Drug Approvals (Drugs@FDA)
EXENATIDE SYNTHETIC
ANDA · Abbreviated New Drug Application (Generic) · Sponsor: AMNEAL · Approved 2024-11-19
Drug application
- FDA Application #
ANDA206697- Application type
- Abbreviated New Drug Application (Generic)
- Brand name
- EXENATIDE SYNTHETIC
- Generic name
- EXENATIDE
- Active ingredients
- EXENATIDE SYNTHETIC
- Dosage form
- INJECTABLE
- Route
- SUBCUTANEOUS
- Marketing status
- Prescription
- Sponsor
- AMNEAL
- Manufacturer
- Amneal Pharmaceuticals LLC
- First approval
- 2024-11-19
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown